Incyte Corp - Company Profile
Powered by 
All the sales intelligence you need on Incyte Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Incyte Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Incyte Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Incyte Corp (Incyte) discovers and develops proprietary small molecule drugs for the treatment of serious chronic inflammatory diseases and cancer. Focus on R&D and robust patent portfolio; expansive product portfolio; marketed product Jakafi; and financial performance are its strengths even as confined geographical operations could be major cause for concern to the company. Incyte could benefit from the regulatory approval, positive outlook of healthcare market in the US, and contracts and agreements. However, uncertain R&D outcomes, stringent government regulations, and lack of manufacturing facilities could affect the company's business.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer